Related Experiment Video
Updated: Jan 7, 2026
Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
STK11 Alleviates Pulmonary Inflammation During Acute Lung Injury by Phosphorylating AMPK to Activate Autophagy in
Rong Xiao1, Zhimin Qi1, Ting Chen2
1Department of Anesthesiology and Operation, The Affiliated Stomatological Hospital, Jiangxi Medical College, Nanchang University, Jiangxi Provincial Key Laboratory of Oral Diseases, Jiangxi Provincial Clinical Research Center for Oral Diseases, Nanchang, 330000, People's Republic of China.
Purpose:
To investigate if protein STK11 alleviates lipopolysaccharide-induced acute lung injury (ALI), hypothesizing it activates autophagy (harmful substance clearance) via AMPK's "start signal".
Methods:
Researchers used a genomics-first approach: they integrated datasets GSE66890, GSE10474, and GSE32707, screened autophagy-related differentially expressed genes in ALI via bioinformatics, and confirmed STK11 as a key regulator through protein-protein interaction analysis. They treated human lung cells with 50 μg/mL lipopolysaccharide for 24 hours to establish ALI models, then overexpressed or silenced STK11 in the cells. They assessed cell function, apoptosis, inflammatory factors, autophagy activity, and AMPK activation.
Results:
Researchers verified STK11 as a key regulator of autophagy in ALI. STK11 overexpression significantly improved cell function, reduced apoptosis (lower pro-apoptotic/higher anti-apoptotic proteins), decreased IL-6/IL-8/TNF-α (mRNA/protein levels), enhanced autophagy (elevated LC3B-II, reduced P62, more autophagosomes), and activated AMPK. STK11 silencing reversed these protective effects and inhibited AMPK.
Conclusion:
STK11 mitigates lipopolysaccharide-induced lung cell damage by activating AMPK-mediated autophagy, emerging as a potential therapeutic target for ALI.
Insights
Protein STK11 alleviates lipopolysaccharide-induced acute lung injury (ALI) by activating AMPK-mediated autophagy. This discovery highlights STK11 as a potential therapeutic target for ALI, offering new hope for treatment.
Area of Science:
- Cell Biology
- Molecular Biology
- Pulmonology
Background:
- Acute Lung Injury (ALI) is a critical condition with limited treatment options.
- Lipopolysaccharide (LPS) is a potent inducer of ALI.
- Autophagy plays a role in cellular defense and injury response.
Purpose of the Study:
- To investigate the role of protein STK11 in mitigating LPS-induced ALI.
- To determine if STK11 activates autophagy via the AMPK signaling pathway.
Main Methods:
- Genomic data integration (GSE66890, GSE10474, GSE32707) to identify key regulators.
- Bioinformatic screening of autophagy-related genes in ALI models.
- In vitro experiments using human lung cells with LPS exposure, STK11 overexpression, and silencing.
Main Results:
- STK11 was confirmed as a key regulator of autophagy in ALI.
- STK11 overexpression improved cell function, reduced apoptosis, and decreased inflammatory markers (IL-6, IL-8, TNF-α).
- STK11 activation enhanced autophagy and AMPK signaling, while silencing reversed these effects.
Conclusions:
- STK11 mitigates LPS-induced lung cell damage by activating AMPK-mediated autophagy.
- STK11 demonstrates potential as a therapeutic target for ALI.
- Targeting the STK11-AMPK-autophagy axis may offer a novel treatment strategy for ALI.
Related Concept Videos
01:22PI3K/mTOR/AKT Signaling Pathway
01:25cAMP-dependent Protein Kinase Pathways